Search results for "alcoholic"

showing 10 items of 509 documents

The dual role of non-selective beta-blockers in cirrhotic patients: How do we know when Dr Jekyll turns into Mr Hyde?

2021

medicine.medical_specialtyDual roleHepatologybusiness.industryLiver Cirrhosis AlcoholicInternal medicineAdrenergic beta-AntagonistsmedicineHumansBeta (finance)businessGastroenterologyFollow-Up StudiesLiver international : official journal of the International Association for the Study of the Liver
researchProduct

Endothelial dysfunction in morbid obesity.

2013

Morbid obesity is a chronic multifunctional disease characterized by an accumulation of fat. Epidemiological studies have shown that obesity is associated with cardiovascular and metabolic disorders. Endothelial dysfunction, as defined by an imbalance between relaxing and contractile endothelial factors, plays a central role in the pathogenesis of these cardiometabolic diseases. Diminished bioavailability of nitric oxide (NO) contributes to endothelial dysfunction and impairs endothelium- dependent vasodilatation. But this is not the only mechanism that drives to endothelial dysfunction. Obesity has been associated with a chronic inflammatory process, atherosclerosis, and oxidative stress. …

medicine.medical_specialtyEndotheliumInflammationVasodilationDiseaseNitric OxideCoronary artery diseaseInternal medicineDiabetes mellitusDrug DiscoveryNonalcoholic fatty liver diseaseWeight LossMedicineAnimalsHumansEndothelial dysfunctionPharmacologyInflammationbusiness.industrymedicine.diseaseAtherosclerosisObesity MorbidVasodilationOxidative Stressmedicine.anatomical_structureEndocrinologyCardiovascular DiseasesEndothelium Vascularmedicine.symptombusinessCurrent pharmaceutical design
researchProduct

Public health policies and alcohol-related liver disease

2019

Summary: Alcohol-related liver disease (ALD) represents a major public health problem worldwide. According to the World Health Organization, the highest levels of per capita alcohol consumption are observed in countries of the European Region. Alcohol consumption is also alarmingly increasing in developing countries. ALD is one of the main contributors to the burden of alcohol-attributable deaths and disability. In the United States, severe forms of ALD such alcoholic hepatitis have increased in the last decade and in the United Kingdom, three-quarters of liver-related mortality results from alcohol consumption. Besides genetic factors, there is strong evidence that the amount of alcohol co…

medicine.medical_specialtyEpidemiologyYouth-focused policiesPublic policyDeveloping countryAlcoholic hepatitisReview03 medical and health sciences0302 clinical medicineEnvironmental healthEpidemiologyInternal MedicinemedicinePer capitaImmunology and AllergyAlcohol-related liver disease030212 general & internal medicinelcsh:RC799-869Alcoholic drinks marketHepatologyPublic healthGastroenterologyMetabolic liver diseasemedicine.disease3. Good healthHarm030211 gastroenterology & hepatologylcsh:Diseases of the digestive system. GastroenterologyBusinessPublic HealthJHEP Reports
researchProduct

Enhanced labelling on alcoholic drinks: reviewing the evidence to guide alcohol policy

2013

Background: Consumer and public health organizations have called for better labelling on alcoholic drinks. However, there is a lack of consensus about the best elements to include. This review summarizes alcohol labelling policy worldwide and examines available evidence to support enhanced labelling. Methods: A literature review was carried out in June-July 2012 on Scopus using the key word 'alcohol' combined with 'allergens', 'labels', 'nutrition information', 'ingredients', 'consumer information' and/or 'warning'. Articles discussing advertising and promotion of alcohol were excluded. A search through Google and the System for Grey Literature in Europe (SIGLE) identified additional source…

medicine.medical_specialtyEvidence-based practicebusiness.industryAlcoholic BeveragesPublic healthPublic Health Environmental and Occupational HealthPoison controlAdvertisingGrey literatureFood LabelingStandard drinkEvidence-Based PracticeLabellingServing sizePractice Guidelines as TopicHumansMedicineHealth educationbusinessNutritive ValueThe European Journal of Public Health
researchProduct

Role of exercise-induced hepatokines in metabolic disorders.

2019

International audience; The health-promoting effects of physical activity to prevent and treat metabolic disorders are numerous. However, the underlying molecular mechanisms are not yet completely deciphered. In recent years, studies have referred to the liver as an endocrine organ, since it releases specific proteins called hepatokines. Some of these hepatokines are involved in whole body metabolic homeostasis and are theorized to participate in the development of metabolic disease. In this regard, the present review describes the role of Fibroblast Growth Factor 21, Fetuin-A, Angiopoietin-like protein 4, and Follistatin in metabolic disease and their production in response to acute exerci…

medicine.medical_specialtyFGF21PhysiologyEndocrinology Diabetes and MetabolismPhysical activity030209 endocrinology & metabolism03 medical and health sciences0302 clinical medicineMetabolic DiseasesRegular exerciseNon-alcoholic Fatty Liver DiseasePhysiology (medical)Internal medicineEndocrine systemMedicineAnimalsHumansObesityMetabolic diseaseBeneficial effectsExercise030304 developmental biology0303 health sciencesbiologybusiness.industry[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism3. Good healthEndocrinologyDiabetes Mellitus Type 2Liverbiology.proteinCytokinesInsulin ResistanceWhole bodybusinessFollistatinAmerican journal of physiology. Endocrinology and metabolism
researchProduct

A human hepatocellular in vitro model to investigate steatosis

2006

The present study was designed to define an experimental model of hepatocellular steatosis with a fat overaccumulation profile in which the metabolic and cytotoxic/apoptotic effects could be separated. This was accomplished by defining the experimental conditions of lipid exposure that lead to significant intracellular fat accumulation in the absence of overt cytotoxicity, therefore allowing to differentiate between cytotoxic and apoptotic effects. Palmitic (C16:0) and oleic (Cl 8: 1) acids are the most abundant fatty acids (FFAs) in liver triglycerides in both normal subjects and patients with nonalcoholic fatty liver disease (NAFLD). Therefore, human hepatocytes and HepG2 cells were incub…

medicine.medical_specialtyHepG2Carcinoma HepatocellularCell SurvivalPalmitic AcidApoptosisBiologyFatty Acids NonesterifiedIn Vitro TechniquesToxicologyfatty acidscellular steatosisPalmitic acidchemistry.chemical_compoundInternal medicineCell Line TumorNonalcoholic fatty liver diseasemedicineHumansCytotoxicityDose-Response Relationship DrugapoptosisGeneral Medicinemedicine.diseaseFatty LiverDose–response relationshipmedicine.anatomical_structureEndocrinologychemistryBiochemistryApoptosisNeutral RedHepatocyteHepatocyteslipids (amino acids peptides and proteins)hepatocytesSteatosisIntracellularOleic Acid
researchProduct

On the value and limitations of liver histology in assessing non-alcoholic steatohepatitis

2020

medicine.medical_specialtyHepatologybusiness.industryBiopsyReproducibility of ResultsNon alcoholicmedicine.diseaseGastroenterologyText miningLiverNon-alcoholic Fatty Liver DiseaseInternal medicinemedicineHumansSteatohepatitisLiver histologybusinessValue (mathematics)Randomized Controlled Trials as TopicJournal of Hepatology
researchProduct

MERTK rs4374383 AA genotype is associated with a lower prevalence of severe hepatic steatosis in non-alcoholic fatty liver disease

2014

medicine.medical_specialtyHepatologybusiness.industryFatty liverGastroenterologyNon alcoholicDiseaseMERTKmedicine.diseaseGastroenterologyInternal medicineGenotypeLower prevalencemedicineSteatosisbusinessDigestive and Liver Disease
researchProduct

Chronic Intermittent Hypoxia is associated with Liver Damage and Atherosclerosis in Patients with Non-alcoholic Fatty Liver Disease

2015

medicine.medical_specialtyHepatologybusiness.industryFatty liverGastroenterologyNon alcoholicDiseasemedicine.diseaseGastroenterologyInternal medicinemedicineChronic intermittent hypoxiaIn patientLiver damagebusinessDigestive and Liver Disease
researchProduct

Hyperuricemia in non-alcoholic fatty liver disease: authors’ reply

2011

medicine.medical_specialtyHepatologybusiness.industryFatty liverGastroenterologyNon alcoholicDiseasemedicine.diseaseGastroenterologyInternal medicinemedicinePharmacology (medical)HyperuricemiabusinessAlimentary Pharmacology & Therapeutics
researchProduct